Your browser doesn't support javascript.
loading
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia.
Del Papa, Beatrice; Baldoni, Stefano; Dorillo, Erica; De Falco, Filomena; Rompietti, Chiara; Cecchini, Debora; Cantelmi, Maria Grazia; Sorcini, Daniele; Nogarotto, Manuel; Adamo, Francesco Maria; Mezzasoma, Federica; Silva Barcelos, Estevão Carlos; Albi, Elisa; Iacucci Ostini, Roberta; Di Tommaso, Ambra; Marra, Andrea; Montanaro, Guido; Martelli, Maria Paola; Falzetti, Franca; Di Ianni, Mauro; Rosati, Emanuela; Sportoletti, Paolo.
Afiliación
  • Del Papa B; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Baldoni S; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Dorillo E; Department of Life, Health and Environmental Sciences, Hematology Section, University of L'Aquila, L'Aquila, Italy.
  • De Falco F; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Rompietti C; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Cecchini D; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Cantelmi MG; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Sorcini D; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Nogarotto M; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Adamo FM; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Mezzasoma F; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Silva Barcelos EC; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Albi E; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Iacucci Ostini R; Department of Biological Sciences, Postgraduate Program in Biotechnology (UFES), Federal University of Espirito Santo, Vitória-ES, Brazil.
  • Di Tommaso A; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Marra A; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Montanaro G; Department of Life, Health and Environmental Sciences, Hematology Section, University of L'Aquila, L'Aquila, Italy.
  • Martelli MP; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Falzetti F; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Di Ianni M; Department of Hematology, Transfusion Medicine and Biotechnologies, Ospedale Civile, Pescara, Italy.
  • Rosati E; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Sportoletti P; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
Clin Cancer Res ; 25(24): 7540-7553, 2019 12 15.
Article en En | MEDLINE | ID: mdl-31578228
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Receptores de Antígenos de Linfocitos B / Leucemia Linfocítica Crónica de Células B / Biomarcadores de Tumor / Apoptosis / Resistencia a Antineoplásicos / Receptor Notch1 Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Receptores de Antígenos de Linfocitos B / Leucemia Linfocítica Crónica de Células B / Biomarcadores de Tumor / Apoptosis / Resistencia a Antineoplásicos / Receptor Notch1 Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Italia